Agenix Biopharmaceutical (Shanghai) is a wholly owned Agenix Limited biopharmaceutical manufacturing organisation, headquartered in Shanghai, China. The company's lead product is a patented next generation prodrug of an anti-hepatitis B virus (HBV) drug, currently under pre-clinical development. The company also has rest-of-world rights to an anti HBV drug marketed in China as You He Ding which on 2 October 2007 received SFDA approval and market introduction in China. In China, YouHeDing is sold directly by its manufacturer and through Sinopharm, the largest medical products and pharmaceutical distributor in China.

The head office of Agenix Biopharmaceutical (Shanghai) is located at Level 5, 159 Ma Dang Rd., Shanghai. In addition, research collaborations have been established in Shanghai and Beijing.

For additional information on Agenix Biopharmaceutical (Shanghai), please click on any of the links to the left.